121 related articles for article (PubMed ID: 7587707)
21. Flow cytometric functional analysis of multidrug resistance by Fluo-3: a comparison with rhodamine-123.
Koizumi S; Konishi M; Ichihara T; Wada H; Matsukawa H; Goi K; Mizutani S
Eur J Cancer; 1995 Sep; 31A(10):1682-8. PubMed ID: 7488425
[TBL] [Abstract][Full Text] [Related]
22. Interaction of rhodamine 123 with living cells studied by flow cytometry.
Darzynkiewicz Z; Traganos F; Staiano-Coico L; Kapuscinski J; Melamed MR
Cancer Res; 1982 Mar; 42(3):799-806. PubMed ID: 7059978
[TBL] [Abstract][Full Text] [Related]
23. Multidrug resistance phenotype evaluation by immunofluorescence and functional tests: comparison of two monoclonal antibodies and three fluorescent dyes in three cells lines.
Maynadie M; Lizard G; Solary E; Roignot P; Carli PM
Anticancer Res; 1994; 14(6B):2605-9. PubMed ID: 7872688
[TBL] [Abstract][Full Text] [Related]
24. [Identification of cells with lowered sensitivity to cytostatic agents by the use of fluorescent dyes].
Neĭfakh AA; Serpinskaia AS
Biull Eksp Biol Med; 1988 Jun; 105(6):684-6. PubMed ID: 2455560
[TBL] [Abstract][Full Text] [Related]
25. Functional study of multidrug resistance with fluorescent dyes. Limits of the assay for low levels of resistance and application in clinical samples.
Canitrot Y; Lahmy S; Buquen JJ; Canitrot D; Lautier D
Cancer Lett; 1996 Aug; 106(1):59-68. PubMed ID: 8827047
[TBL] [Abstract][Full Text] [Related]
26. Rhodamine 123 efflux in drug resistance assays.
Pétriz J; O'Connor JE; García-López J
Leukemia; 1996 Apr; 10(4):748-9. PubMed ID: 8618459
[No Abstract] [Full Text] [Related]
27. Reciprocal correlation between expression of P-glycoprotein and accumulation of rhodamine 123 in human tumors.
Efferth T; Löhrke H; Volm M
Anticancer Res; 1989; 9(6):1633-7. PubMed ID: 2576349
[TBL] [Abstract][Full Text] [Related]
28. Detection and quantitation of cell-cell electrofusion products by flow cytometry.
Jaroszeski MJ; Gilbert R; Heller R
Anal Biochem; 1994 Feb; 216(2):271-5. PubMed ID: 7513970
[TBL] [Abstract][Full Text] [Related]
29. Monitoring of cellular resistance to cancer chemotherapy: drug retention and efflux.
Krishan A
Methods Cell Biol; 2001; 64():193-209. PubMed ID: 11070840
[No Abstract] [Full Text] [Related]
30. [The kinetics of rhodamine 123 efflux from cells with multiple drug resistance under the action of energy metabolism inhibitors].
Gamaleĭ IA; Berezkina EV; Kovaleva ZV; Ignatova TN
Tsitologiia; 1995; 37(1-2):118-25. PubMed ID: 7571015
[TBL] [Abstract][Full Text] [Related]
31. Chemosensitization and drug accumulation assays as complementary methods for the screening of multidrug resistance reversal agents.
Quesada AR; Barbacid MM; Mira E; Aracil M; Márquez G
Cancer Lett; 1996 Jan; 99(1):109-14. PubMed ID: 8564921
[TBL] [Abstract][Full Text] [Related]
32. Detection of human leukemia cells with multidrug-resistance phenotype using multilabeling with fluorescent dyes.
Lautier D; Lahmy S; Canitrot Y; Vigo J; Viallet P; Salmon JM
Anticancer Res; 1993; 13(5A):1557-63. PubMed ID: 8239535
[TBL] [Abstract][Full Text] [Related]
33. Carrier-mediated uptake of rhodamine 123: implications on its use for MDR research.
Cho CW; Liu Y; Yan X; Henthorn T; Ng KY
Biochem Biophys Res Commun; 2000 Dec; 279(1):124-30. PubMed ID: 11112427
[TBL] [Abstract][Full Text] [Related]
34. A novel method for direct and fluorescence independent determination of drug efflux out of leukemic blast cells.
Schaich M; Neu S; Beck J; Gekeler V; Schuler U; Ehninger G
Leuk Res; 1997 Oct; 21(10):933-40. PubMed ID: 9403004
[TBL] [Abstract][Full Text] [Related]
35. Efficiency of P-glycoprotein-mediated exclusion of rhodamine dyes from multidrug-resistant cells is determined by their passive transmembrane movement rate.
Eytan GD; Regev R; Oren G; Hurwitz CD; Assaraf YG
Eur J Biochem; 1997 Aug; 248(1):104-12. PubMed ID: 9310367
[TBL] [Abstract][Full Text] [Related]
36. Flow cytometric monitoring of fluorescent drug retention and efflux.
Krishan A; Hamelik RM
Methods Mol Med; 2005; 111():149-66. PubMed ID: 15911978
[TBL] [Abstract][Full Text] [Related]
37. [Functional detection of P-glycoprotein expressing cells with flow cytometry].
Ludescher C; Hilbe W; Eisterer W; Preuss E; Hofmann J; Thaler J
Wien Klin Wochenschr; 1994; 106(8):242-6. PubMed ID: 7912868
[TBL] [Abstract][Full Text] [Related]
38. Rapid stimulation of rhodamine 123 efflux from multidrug-resistant KB cells by progesterone.
Jancis EM; Chen HX; Carbone R; Hochberg RB; Dannies PS
Biochem Pharmacol; 1993 Nov; 46(9):1613-9. PubMed ID: 7902090
[TBL] [Abstract][Full Text] [Related]
39. [Assessment of P glycoprotein expression by immunocytochemistry and flow cytometry coupled with functional efflux analysis: application to acute myeloid leukemia].
Poulain S; Lepelley P; Cambier N; Wattel E; Fenaux P; Cosson A
Ann Biol Clin (Paris); 1999; 57(5):595-600. PubMed ID: 10518062
[TBL] [Abstract][Full Text] [Related]
40. SDZ PSC 833 and SDZ 280-446 are the most active of various resistance-modifying agents in restoring rhodamine-123 retention within multidrug resistant P388 cells.
Pourtier-Manzanedo A; Didier AD; Muller CD; Loor F
Anticancer Drugs; 1992 Aug; 3(4):419-25. PubMed ID: 1421439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
